20 May 2013
Keywords: immtech, pafuramidine, enters, ph, iib, trial, usa
Article | 16 April 2007
The USA's Immtech Pharmaceuticals has initiated a Phase IIb clinical trial of its oral drug candidate pafuramidine maleate in patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 April 2007
17 May 2013
© 2013 thepharmaletter.com